GC Wealth Management RIA LLC Raises Stock Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• GC Wealth Management RIA LLC increased its holdings in Intuitive Surgical, Inc. by 349.5% during the second quarter, owning 8,940 shares worth approximately $4.86 million.
• Insider selling included Director Amy L. Ladd, who sold 335 shares at an average price of $440.69, and insider Gary S. Guthart, who sold 29,360 shares for over $13.87 million.
• Analysts have mixed ratings for Intuitive Surgical, with a consensus of "Moderate Buy" and a target price averaging $595.95.

GC Wealth Management RIA LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 349.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,940 shares of the medical equipment provider's stock after purchasing an additional 6,951 shares during the quarter. GC Wealth Management RIA LLC's holdings in Intuitive Surgical were worth $4,858,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of ISRG. Alpine Bank Wealth Management increased its holdings in shares of Intuitive Surgical by 23.7% in the 2nd quarter. Alpine Bank Wealth Management now owns 162 shares of the medical equipment provider's stock worth $88,000 after buying an additional 31 shares during the last quarter. Hanson & Doremus Investment Management lifted its holdings in shares of Intuitive Surgical by 110.3% during the 2nd quarter. Hanson & Doremus Investment Management now owns 2,902 shares of the medical equipment provider's stock worth $1,577,000 after acquiring an additional 1,522 shares during the last quarter. V Square Quantitative Management LLC grew its position in Intuitive Surgical by 31.6% in the second quarter. V Square Quantitative Management LLC now owns 4,873 shares of the medical equipment provider's stock worth $2,648,000 after acquiring an additional 1,170 shares in the last quarter. Vermillion Wealth Management Inc. increased its stake in Intuitive Surgical by 232.6% in the second quarter. Vermillion Wealth Management Inc. now owns 143 shares of the medical equipment provider's stock valued at $78,000 after acquiring an additional 100 shares during the last quarter. Finally, Scott & Selber Inc. lifted its stake in Intuitive Surgical by 0.6% during the second quarter. Scott & Selber Inc. now owns 6,788 shares of the medical equipment provider's stock worth $3,689,000 after purchasing an additional 40 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 335 shares of the firm's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the transaction, the director owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last three months. Company insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent research reports. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Piper Sandler reaffirmed an "overweight" rating and issued a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wall Street Zen downgraded Intuitive Surgical from a "buy" rating to a "hold" rating in a research report on Friday. Royal Bank Of Canada restated an "outperform" rating and issued a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. Finally, Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $595.95.

Intuitive Surgical Stock Up 0.7%

NASDAQ:ISRG opened at $441.12 on Monday. The firm's fifty day simple moving average is $469.43 and its 200 day simple moving average is $501.66. The stock has a market cap of $158.13 billion, a P/E ratio of 61.52, a price-to-earnings-growth ratio of 4.62 and a beta of 1.61. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's quarterly revenue was up 21.4% compared to the same quarter last year. During the same period last year, the company posted $1.78 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.